ARCHIVES

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

This article is from The Cancer Letter archive.

Vol. 27 No. 31 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

Doctor-Patient Conversations At End of Life Associated With Lower Medical Expenses

March 27, 2009

NCCN Launches Outcomes Improvement Program

August 12, 2011

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986

The Donald Pinkel Archive

May 21, 2021

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992